112
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Transdermal delivery of car vedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract–chitosan mixture

, &
Pages 1230-1241 | Received 15 Jan 2009, Accepted 09 Mar 2009, Published online: 08 May 2009

References

  • Klimentová J, Kosák P, Vávrová K, Holas T, Novotný J, Hrabálek A. (2008). Transkarbams with terminal branching as transdermal permeation enhancers. Bioorg Med Chem Lett, 18:1712–5.
  • Vávrová K, Lorencová K, Novotný J, Holý A, Hrabálek A. (2008). Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species. Eur J Pharm Biopharm, 70:901–7.
  • Vávrová K, Lorencová K, Klimentová J, Novotný J, Holý AN, Hrabálek A. (2008). Transdermal and dermal delivery of adefovir: Effects of pH and permeation enhancers. Eur J Pharm Biopharm, 69:597–604.
  • Novotný J, Kovaříková P, Novotný M, Janůšová B, Hrabálek A, Vávrová K. (2008). Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: Effects of linking chain length, chirality and polyfluorination. Pharm Res, 26(4):811–21.
  • Novotný M, Hrabálek A, Janůšová B, Novotný J, Vávrová K. (2009). Dicarboxylic acid esters as transdermal permeation enhancers: Effects of chain number and geometric isomers. Bioorg Med Chem Lett, 19:344–7.
  • Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. (2008). Percutaneous permeation modifiers: Enhancement versus retardation. Expert Opin Drug Deliv, 5:517–29.
  • Shah VP. (1994). Skin penetration enhancers: Scientific perspective. In: Hsieh DS, ed. Drug permeation and enhancement, New York: Marcel Dekker, 19–23.
  • Weerheim A, Ponec M. (2001). Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res, 293:191–9.
  • Barry BW, Bennett SL. (1987). Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol, 39:535–46.
  • Bodde HE, Van den Brink I, Koerten HK, Dehaan FHN. (1991). Visualization of in vitro percutaneous penetration of mercuric chloride transport through intercellular space versus cellular uptake through desmosomes. J Control Release, 15:227–36.
  • Elias PM. (1983). Epidermal lipids, barrier function, and desquamation. J Invest Dermatol, 80:44S–9S.
  • Babita K, Rana V, Tiwary AK. (2005). Lipid synthesis inhibitors: Effect on epidermal lipid conformational changes and percutaneous permeation of levodopa. AAPS PharmSciTech, 6:E473–81.,
  • Kumar B, Tiwary AK. (2005). Transcutaneous delivery of levodopa: Enhancement by fatty acid synthesis inhibition. Mol Pharm, 2:57–63.
  • Davar K. (1997). Drug-surfactant interactions: Effect on transport properties. Int J Pharm, 155:179–90.
  • Goodman M, Barry BW. (1988). Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J Invest Dermatol, 91:323–7.
  • Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res, 42:1–36.
  • Smith J, Wood E, Dornish M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res, 21:43–9.
  • Shigeru A, Yoshihiro U. (1985). Soybean saponins, and a method of isolating the same. US patent no. 4524067.
  • Kligman AM, Christophers E. (1963). Preparation of isolated sheets of human stratum corneum. Arch Dermatol, 88:702–5.
  • Folch J, Lees M, Sloane-Stanley GH. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 226:497–502.
  • Sabbadini R, McNutt WM, Jenkins G, Betto R, Salviati G. (1993). Sphingosine is endogenous to cardiac and skeletal muscle. Biochem Biophys Res Commun, 3:752–8.
  • Singh S, Bi M, Jayaswal SB, Singh J. (1998). Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis. Int J Pharm, 166:157–66.
  • Van den Bergh BAI, Swartzendruber DC, Geest AB, Hoogstraate JJ, Schrijvers AHGJ, Bodde HE, al et. (1997). Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J Microsc, 187:125–33.
  • Rogiers V. (1995). TEWL-measurements in patch test assessment: The need for standardization. In: Elsner P, Maibach HI, eds. Irritant dermatitis, new clinical and experimental aspects (Current problems in Dermatology), Basel: Karger, 152–8.
  • Khazaei M, Nematbakhsh M. (2006). The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-salt hypertensive overiectomized rats. Regul Pept, 135:91–4.
  • Nokhodchi A, Nazemiyeh H, Ghafourian T, Hassan-Zadeh D, Valizadeh H, Bahary LA. (2002). The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Farmaco, 57(11):883–8.
  • Shokri J, Nokhodchi A, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Jalali MB. (2001). The effect of surfactants on the skin permeation of diazepam. Int J Pharm, 228:99–107.
  • Gibaldi M, Feldman S. (1970). Mechanisms of surfactant effects on drug absorption. J Pharm Sci, 59:579–89.
  • Abrams K, Harvell JD, Shriner D, Wertz P, Maibach H, Maibach HI, Rehfeld SJ. (1993). Effect of organic solvents on in vitro human skin water barrier function. J Invest Dermatol, 101:609–13.
  • Yamashita N, Tachibana K, Ogawa K, Tsujita N, Tomita A. (1997). Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat Rec, 247:455–61.
  • Bouwstra JA, Cheng K, Gooris GS, Weerheim A, Ponec M. (1996). The role of ceramides 1 and 2 in the stratum corneum lipid organization. Biochim Biophys Acta, 1300:177–86.
  • Lavker RM. (1979). Membrane-coating granules: The fate of the discharged lamellae. J Ultrastruct Res, 55:79–86.
  • Lampe MA, Williams ML, Elias PM. (1983). Human epidermal lipid characterization and modulation during differentiation. J Lipid Res, 24:131–40.
  • Fujimaki M, Hakusui H, Hasegawa Y, Ajima H, Ota H, Igafashi S, al et. (1990). Pharmacokinetics of carvedilol (DQ-2466) in healthy subjects. Jpn J Clin Pharmacol Ther, 21:415–24.
  • Hokama N, Hobra N, Kameya H, Ohshiro S, Sakanashi M. (1999). Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J Chromatogr B, 732:233–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.